BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 31524010)

  • 1. Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine.
    Zhang L
    Drug Deliv; 2019 Dec; 26(1):860-869. PubMed ID: 31524010
    [No Abstract]   [Full Text] [Related]  

  • 2. Self-microemulsifying drug delivery systems (SMEDDS) for improving in vitro dissolution and oral absorption of Pueraria lobata isoflavone.
    Cui S; Zhao C; Chen D; He Z
    Drug Dev Ind Pharm; 2005 May; 31(4-5):349-56. PubMed ID: 16093200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin.
    Gu L; Wu Zh; Qi X; He H; Ma X; Chou X; Wen X; Zhang M; Jiao F
    Pharm Dev Technol; 2013; 18(5):1051-7. PubMed ID: 22303809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation of puerarin solid self-microemulsion].
    Yu AH; Zhai GX; Cui J; Liu H
    Zhong Yao Cai; 2006 Aug; 29(8):834-8. PubMed ID: 17076244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the bioavailability of puerarin from Pueraria lobata isoflavone self-microemulsifying drug-delivery systems and tablets in rabbits by liquid chromatography-mass spectrometry.
    Cui S; Zhao C; Tang X; Chen D; He Z
    Biomed Chromatogr; 2005 Jun; 19(5):375-8. PubMed ID: 15627278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics and bioavailability of Puerarin self-microemulsion in Beagle dogs].
    Chen XX; Yuan S; Li G; Liang YY; Zhou X; Xie CS; Long CF
    Zhong Yao Cai; 2011 May; 34(5):750-3. PubMed ID: 21954564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced oral bioavailability of puerarin using microemulsion vehicle.
    Wu H; Lu C; Zhou A; Min Z; Zhang Y
    Drug Dev Ind Pharm; 2009 Feb; 35(2):138-44. PubMed ID: 19040180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmaceutics research advances in oral administration of puerarin].
    Wu WT; Zou B; Li WD; Zhu WF
    Zhongguo Zhong Yao Za Zhi; 2019 Oct; 44(19):4134-4141. PubMed ID: 31872690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat.
    Tu L; Yi Y; Wu W; Hu F; Hu K; Feng J
    Int J Pharm; 2013 Dec; 458(1):135-40. PubMed ID: 24120729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puerarin: a review of pharmacological effects.
    Zhou YX; Zhang H; Peng C
    Phytother Res; 2014 Jul; 28(7):961-75. PubMed ID: 24339367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of UDP-glucuronosyltransferase 1a1, 1a7 and P-glycoprotein expression in hepatic fibrosis rats and the impact on pharmacokinetics of puerarin.
    Zhang MF; Liu YX; Jiang KY; Niu HM; Jiang JL; Dong ST; Wang X; Wang DF; Meng SN
    Phytomedicine; 2019 Jan; 52():264-271. PubMed ID: 30599907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Methods of Puerarin Biotransformation.
    Liu G; Liu Z; Yuan S
    Mini Rev Med Chem; 2016; 16(17):1392-1402. PubMed ID: 27145856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery.
    Zhang Y; Wang R; Wu J; Shen Q
    Int J Pharm; 2012 May; 427(2):337-44. PubMed ID: 22366381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Puerarin: A review of its mechanisms of action and clinical studies in ophthalmology.
    Meng F; Guo B; Ma YQ; Li KW; Niu FJ
    Phytomedicine; 2022 Dec; 107():154465. PubMed ID: 36166943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Oral Bioavailability of Pueraria Flavones by a Novel Solid Self-microemulsifying Drug Delivery System (SMEDDS) Dropping Pills.
    Guan Q; Zhang G; Sun S; Fan H; Sun C; Zhang S
    Biol Pharm Bull; 2016 May; 39(5):762-9. PubMed ID: 26935150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Activity, Pharmacokinetics, and Clinical Research Progress of Puerarin.
    Wang D; Bu T; Li Y; He Y; Yang F; Zou L
    Antioxidants (Basel); 2022 Oct; 11(11):. PubMed ID: 36358493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and pharmacokinetics evaluation of puerarin nanocrystals for intravenous delivery.
    Wang Y; Ma Y; Ma Y; Du Y; Liu Z; Zhang D; Zhang Q
    J Nanosci Nanotechnol; 2012 Aug; 12(8):6176-84. PubMed ID: 22962724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A microemulsion of puerarin-phospholipid complex for improving bioavailability: preparation, in vitro and in vivo evaluations.
    Wu JY; Li YJ; Han M; Hu XB; Yang L; Wang JM; Xiang DX
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1336-1341. PubMed ID: 29513046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of puerarin against cerebral diseases: From bench to bedside.
    Liu T; Su K; Cai W; Ao H; Li M
    Eur J Pharmacol; 2023 Aug; 953():175695. PubMed ID: 36977450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute oral bioavailability and disposition kinetics of puerarin in female rats.
    Anukunwithaya T; Poo P; Hunsakunachai N; Rodsiri R; Malaivijitnond S; Khemawoot P
    BMC Pharmacol Toxicol; 2018 May; 19(1):25. PubMed ID: 29801513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.